Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor miRNAs
Angelica Pace(Sapienza University of Rome), Aurelia Rughetti(Sapienza University of Rome)
Cited by 1
Related Papers
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
|Immunity|2024|252
Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation
|Cancer Discovery|2025|50
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
|Journal of Personalized Medicine|2020|44
Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma
|Journal of Personalized Medicine|2020|38
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer
|Clinical Cancer Research|2022|30